Neuropace company information, Employees & Contact Information

NeuroPace to Report Third Quarter 2025 Financial Results on November 4, 2025 Business Wire

NeuroPace Announces Data From a Long-Term Post-Approval GlobeNewswire

NeuroPace Beats Q2 Targets With Record $23.5M Revenue, Lifts Full-Year Guidance on Strong Epilepsy Device Sales Stock Titan

NeuroPace to Participate in Upcoming Healthcare Conferences Business Wire

NeuroPace Secures Up to $75 Million in Debt Financing GlobeNewswire

Medical Device Maker NeuroPace Sets Q2 Earnings Date: Key Updates Expected for Epilepsy Treatment Leader Stock Titan

Q&A: Neuromodulation device effective for drug-resistant focal epilepsy, 3-year data show Healio

Responsive Neurostimulation (RNS) Epilepsy Foundation

Reconstructing signal during brain stimulation with Stim-BERT: a self-supervised learning model trained on millions of iEEG files Frontiers

Safety and Management of Implanted Epilepsy Devices for Imaging and Surgery Mayo Clinic Proceedings

Breakthrough: New Epilepsy Device Shows 82% Seizure Reduction, FDA Study Reveals Stock Titan

Earnings call transcript: NeuroPace beats Q1 2025 EPS forecast, stock rises Investing.com

Using vision transformers for electrographic seizure classification to aid physician review of intracranial electroencephalography recordings Frontiers

$75M Financing Fuels NeuroPace's Epilepsy Treatment Expansion: 5 Key Growth Initiatives Revealed Stock Titan

NeuroPace to Report Third Quarter 2022 Financial Results on November 8, 2022 GlobeNewswire

NeuroPace NAUTILUS Trial: Mixed Results Show Promise for Revolutionary Epilepsy Treatment Stock Titan

FDA Approves MRI Labeling for Neurostimulation System Designed to Prevent Seizures Medical Professionals Reference

First Patient Treated in Adolescent Epilepsy Trial Assessing NeuroPace RNS System NeurologyLive

Long-term treatment with responsive brain stimulation in adults with refractory partial seizures Neurology® Journals

FDA Approves MRI Labeling for NeuroPace RNS System NeurologyLive

NeuroPace Lennox-Gastaut Syndrome Study Completes Enrollment Medical Device and Diagnostic industry

NeuroPace RNS System Shows Continued Success in Interim Post-Approval Results NeurologyLive

Non-linear Embedding Methods for Identifying Similar Brain Activity in 1 Million iEEG Records Captured From 256 RNS System Patients Frontiers

NIH Awards Funding to Study RNS System in Lennox-Gastaut Syndrome NeurologyLive

Expert and deep learning model identification of iEEG seizures and seizure onset times Frontiers

Neurostimulation and Targeted Treatment Delivery in Epilepsy Care: Martha Morrell, MD NeurologyLive

Earnings call transcript: Neuropace Q2 2025 sees revenue rise; stock gains 2.7% Investing.com

A High Accuracy Electrographic Seizure Classifier Trained Using Semi-Supervised Labeling Applied to a Large Spectrogram Dataset Frontiers

NeuroPace stock falls as trial for RNS System fails (NPCE:NASDAQ) Seeking Alpha

NeuroPace - Volatile, Uncertain, But Promising (NASDAQ:NPCE) Seeking Alpha

NeuroPace reports one-year data on neuromodulation therapy for epilepsy MassDevice

Postmortem Protocols of Implantable Neurosurgical Devices: A Cross-Sectional Survey ScienceDirect.com

Brain‐responsive neurostimulation in patients with medically intractable mesial temporal lobe epilepsy Wiley Online Library

Keeping Track: Wearable tech and health monitoring Chicago Health Magazine

NPCE Investors Have Opportunity to Join NeuroPace, Inc. Fraud Investigation with the Schall Law Firm PR Newswire

NPCE IPO News - Epilepsy medical device developer NeuroPace files for a $75 million IPO renaissancecapital.com

Brain‐responsive neurostimulation in patients with medically intractable seizures arising from eloquent and other neocortical areas Wiley Online Library

Top 10 Deep Brain Stimulation Device Companies | Provides Best Devices Market.us Media

Differential neuropsychological outcomes following targeted responsive neurostimulation for partial-onset epilepsy Wiley Online Library

NeuroPace implant zaps epileptic seizures SFGATE